David Moreira Appointed Vice President of Marketing, Menicon America

NAGOYA, Japan, July 20, 2010 – -Menicon focusing on expanding its presence in the custom contact lens
market-

Menicon Co., Ltd. announced on July 20 the appointment of David Moreira
as Vice President of Marketing for Menicon America Inc. Moreira will report
to Jonathan Jacobson, President of Menicon America.
Moreira joins [...]

World’s Largest Study on Insulin Therapy Completes Recruitment With 60,000 Patients

ZURICH, July 19, 2010 – Today, Novo Nordisk announced the landmark recruitment of the 60,000th
patient in the A1chieve(R) study – an observational study designed to
investigate the effects of modern insulins in the management of type 2
diabetes.[1]

Spanning 28 countries across 4 continents and involving more than 3300
physicians, A1chieve(R) is set to [...]

Visage Imaging Releases Amira 5.3

Introducing a new powerful toolset for Neuroscience and a multitude of new features and improvements

SAN DIEGO, California, July 19, 2010 – Visage Imaging(R), Inc., a wholly owned subsidiary of Pro Medicus Ltd.
(ASX: PME), is pleased to announce the immediate release of Amira 5.3, a new
major version of its market-leading software platform for visualizing,
analyzing, and [...]

Abbott’s PROGRESS Study of Kaletra and Isentress Compared with a Standard HIV Regimen Meets the Pre-Specified Primary Efficacy Endpoint

PROGRESS is the First Study to Present 48-Week Efficacy Results for this Combination When Used in Treatment-Naive Patients with HIV

VIENNA, July 19, 2010 – Abbott (NYSE: ABT) today presented 48-week findings comparing an HIV
regimen of its protease inhibitor (PI), Kaletra(R) (lopinavir/ritonavir), and
Merck's integrase inhibitor, Isentress(R) (raltegravir), to a traditional HIV
regimen of Kaletra and the [...]

Bill Gates: World Has Historic Opportunity to ‘Change the Face of AIDS’

In Keynote Speech to AIDS Conference, Gates Outlines Roadmap to Reduce Annual New HIV Infections 90% by 2031

VIENNA, July 19, 2010 – Speaking to the 18th International AIDS Conference today, Bill Gates
called on all countries to keep up the fight against HIV/AIDS, saying the
world has an historic opportunity to "change the face of AIDS." [...]

Corgenix Medical Corp. and the ELITech Group Establish Strategic Alliance

Terms include initial US$1.25 million ELITech equity investment in Corgenix with options for US$3 million total, plus distribution agreement and diagnostic system co-development

DENVER and PARIS, July 19, 2010 – Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide
developer and marketer of diagnostic test kits, and the ELITech Group, a
Paris, France-based, privately held group of [...]

Amira Pharmaceuticals Hits Two Development Milestones Related to FLAP Inhibitor Program

SAN DIEGO, July 19, 2010 – "Amira Pharmaceuticals, Inc. announced today that its FLAP
(5-lipoxygenase-activating protein) program, which is partnered with
GlaxoSmithKline, has achieved two clinical development milestones."

These milestones are related to the successful progression of the program
to Phase 2 studies, which explore the use of the Amira discovered FLAP
inhibitor in patients [...]

International Organizations Agree to Take Concerted Action to End Pediatric HIV/AIDS

"No child should enter this world infected with HIV."
VIENNA, July 19, 2010 – A global alliance of international organizations, including the heads of
UNICEF, UNAIDS and The Global Fund to Fight AIDS, Tuberculosis and Malaria as
well as other NGOs including the Pan African Treatment Access Movement,
Health GAP, Ugandan Pediatric Association and the Global AIDS Alliance [...]

ThromboGenics Announces Publication of Positive Microplasmin Phase II Data in the Journal Retina

Paper Highlights the Potential of Microplasmin for Nonsurgical Treatment of Vitreomacular Adhesion

LEUVEN, Belgium, July 15, 2010 – ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical
company focused on the discovery and development of innovative treatments for
eye disease, vascular disease and cancer, announces today that positive
microplasmin Phase II trial results, evaluating the product for the
nonsurgical treatment of [...]

Oasmia Pharmaceutical AB, Sweden – Listing Prospectus: NASDAQ OMX Stockholm

A Number of Promising New Product Candidates for Cancer Treatment, Within Both Human and Veterinary Oncology

UPPSALA, Sweden, July 15, 2010 – ABOUT OASMIA
Oasmia is developing a new generation of drugs with emphasis
on human and veterinary oncology. Our main business activity focuses on
improving product life cycles and the versatility of current [...]

New Psoriasis eCommerce Shop Launched by PAPAA

ST ALBANS, England, July 15, 2010 – The Psoriasis and Psoriatic Arthritis Alliance (PAPAA) has launched a new
secure eCommerce site www.psoriasis-shop.org . Visitors can now order
free information, pay and renew their subscription, make donations and buy
from a selection of publications aimed at providing practical information on
these conditions.

A spokesperson for the [...]

Varicent to Provide Global Eye Care Leader Alcon With Global Solution for Sales Performance Management

Varicent expected to enhance sales performance management functionality for multiple geographic business units

TORONTO, July 15, 2010 – Varicent Software Incorporated, the leading innovator in incentive
compensation (ICM) and sales performance management (SPM) solutions,
announced today that it will provide its innovative solutions to Alcon, the
world's largest eye-care company.
Alcon Japan recently chose Varicent [...]

Frost & Sullivan Recognizes Camozzi spa for Outstanding Customer Service in the Western European Pneumatic Valves Market

LONDON, July 15, 2010 – Based on its recent research on the pneumatic valves market, Frost &
Sullivan presents Camozzi spa with the "2010 Western European Customer
Service Leadership Award." The mature and consolidated pneumatic valves
market in Western Europe requires manufacturers to excel in the area of
customer service for gaining a competitive edge. Camozzi spa has [...]

Second Quarter 2010 Results Date Notification – August 4, 2010

DUBLIN, July 15, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, will announce second quarter 2010 earnings on
Wednesday August 4, 2010.

Results press release will be issued at: 12:00 BST / 07:00 EDT
Investor conference call time: [...]

JuvoLab Announces Results of Study Analyzing Entire Global Oncology Community’s Twitter Usage at ASCO 2010

First-ever aggregate analysis of physician, pharmaceutical and biotechnology industry, academic association, institution, journal, marketing and communications industry, non-profit organization, and patient advocate social media usage to discuss and disseminate breaking data and conduct compliant corporate promotion at the 2010 American Society of Clinical Oncology Annual Meeting (ASCO) released today

NEW YORK, July 15, 2010 – [...]

Agendia to Provide Testimony at Public Meeting on FDA Oversight of Laboratory-Developed Tests

World Leader in Cancer Diagnostics Joins Nation's Top Safety Agency in Calling for Risk-Based Oversight of Genomic Testing

IRVINE, California, and AMSTERDAM, July 15, 2010 – Agendia, a world leader in molecular cancer diagnostics, announced today
that company CEO Dr. Bernhard Sixt will provide testimony at a public meeting
on July 20 in Washington D.C. on the [...]

NEXUS Biosystems Acquires Tecan Group’s REMP Sample Management Business

POWAY, California, July 15, 2010 – NEXUS Biosystems, Inc., a leading innovator and worldwide provider of
automated sample management systems, today announced the signing of an
agreement to acquire REMP AG, a wholly-owned subsidiary of Tecan, as well as
other related assets. Under this agreement, NEXUS will acquire all activities
of Tecan's REMP(R) Sample Management business segment from [...]

Substantial Revenues and Earnings Plus for Gerresheimer

D??SSELDORF, Germany, July 14, 2010 -

– Group Revenues in the Second Quarter up by 6.8% (Excluding
Technical Plastic Systems)

– Further Solid Growth of the Pharma Business – Improvement in
the Cosmetics and Life Science Research Segments

[...]

New Procedures Consult Mobile From Elsevier Enables Clinicians to View Top Medical Procedures From Mobile Devices

Physicians, Residents and Students now Able to Prepare, Review and Test Knowledge of Common Medical Procedures Anywhere, Anytime

PHILADELPHIA, Pennsylvania, July 14, 2010 – Elsevier, the world's leading publisher of scientific, technical, and
medical information products and services, announced today that physicians,
residents and students will be able to visualize and review over 300 top
medical procedures on [...]

Increased Need for Remote Patient Monitoring Drives the Data Management Systems for Patient Monitoring Markets in Europe, Finds Frost & Sullivan

LONDON, July 14, 2010 – The increased need for real-time data management and the improved
receptiveness of a technology to monitor patients effectively are driving the
markets for data management systems (DMS) for patient monitoring in Europe.
The participants are looking for options that allow physicians to manage the
massive data collected and help reduce errors caused by [...]

David Moreira Appointed Vice President of Marketing, Menicon America

NAGOYA, Japan, July 20, 2010 – -Menicon focusing on expanding its presence in the custom contact lens
market-

Menicon Co., Ltd. announced on July 20 the appointment of David Moreira
as Vice President of Marketing for Menicon America Inc. Moreira will report
to Jonathan Jacobson, President of Menicon America.
Moreira joins [...]

Bristol-Myers Squibb Foundation’s SECURE THE FUTURE(R) Works to Reduce the Impact of HIV and Tuberculosis Epidemic in Africa

Community-Based Programs Confront Challenges Associated With Dual Epidemic -

VIENNA, July 20, 2010 – Bristol-Myers Squibb Company (NYSE: BMY) and the Bristol-Myers Squibb
Foundation announced at the XVIII International AIDS Conference in Vienna the
community-based projects that it is currently supporting in resource-poor
regions across Africa to help combat the challenge of HIV and tuberculosis
co-infection.
[...]

Frost & Sullivan: Consumers Becoming Increasingly Savvy About Marine and Algae Oil Omega-3 Ingredients

LONDON, July 20, 2010 – The flood of scientific evidence on omega-3 eicosapentaenoic
acid/docosahexaenoic acid (EPA/DHA) has significantly buoyed the credibility
of polyunsaturated fatty acids (PUFAs) as vital functional ingredients.
Heightened consumer awareness has had a telling effect on the healthy growth
charts of the marine and algae oil omega-3 ingredients market.

(Logo: photos.prnewswire.com/prnh/20081117/FSLOGO)
[...]

Operational Agility Forum Launched – New Thought Leadership Forum to Focus on the Challenge of Achieving Agility in Business Operations

Senior IT and Business Professionals Create New Forum to Focus on the Challenge of Achieving Operational Agility

LONDON, July 20, 2010 – A new interest group called the Operational Agility Forum has been
established by senior information technology and business professionals who
represent some of the largest users of IT in the UK. Members of the forum
work [...]

PSI and Partners Join Call for Male Circumcision Scale Up

WHO, US Global AIDS Coordinator, and noted academic highlight ways to maximize impact of the life-saving intervention at the International AIDS Conference in Vienna

VIENNA, July 20, 2010 – The U.S. Global AIDS Coordinator Ambassador Eric Goosby and the World
Health Organization's Director of HIV, TB, and Malaria, Africa Regional
Office, Dr. David Okello, joined PSI (Population [...]

ARUP Laboratories Ink Partnership to Offer deCODE ProstateCancer(TM) Test

U.S. Laboratories and Physicians Will be Able to use Their ARUP Accounts to Order deCODE's Test for Assessing Risk of Prostate Cancer

Reykjavik, ICELAND, and Salt Lake City, UTAH, July 20, 2010 – deCODE genetics and ARUP Laboratories today announced a partnership
through which ARUP will offer deCODE's DNA-based prostate cancer risk
assessment test to its clients [...]

Health Robotics’ CytoCare Continues European Expansion With Grifols and Vall d’Hebron University Hospital

BOZEN, Sud-Tirol, Italy, July 20, 2010 – Health Robotics today announced that it recently signed agreements to
grant exclusive CytoCare distribution rights in Spain and Portugal to
world-leading IV Therapy company Grifols S.A., and to install the first-ever
Cancer Therapy Robot in Spain at Vall d'Hebron University Hospital in
Barcelona in November 2010.

"We are [...]

MEDcounselor Drug Information Now Available on ISMP’s ConsumerMedSafety.org

MEDcounselor's Drug Information, Drug IDentifier and Drug Interactions Modules Help Consumers Take Medications Safely, Avoid Errors

TAMPA, Florida, July 20, 2010 – Gold Standard/Elsevier, developer of drug information and
medication management solutions, announced today that the Institute for Safe
Medication Practices (ISMP) has licensed MEDcounselor (
www.goldstandard.com/pages/medCounselor.html?epm=1_1) Drug
Information, Drug IDentifer and Drug Interaction modules for its consumer
website, ConsumerMedSafety.org [...]

MarketsandMarkets Partners With Centre of Business Intelligence (CBI) for its Market Research and Product Forecasting Summit

DALLAS, July 20, 2010 – Event Date- July 26 – 27, 2010

Location- Philadelphia, PA
About the event:
Join your colleagues and peers to discuss optimizing, executing and
improving market research to drive accurate sales forecasting. This is a
unique opportunity for pharmaceutical executives to hear best [...]

Abbott’s PROGRESS Study of Kaletra and Isentress Compared with a Standard HIV Regimen Meets the Pre-Specified Primary Efficacy Endpoint

PROGRESS is the First Study to Present 48-Week Efficacy Results for this Combination When Used in Treatment-Naive Patients with HIV

VIENNA, July 19, 2010 – Abbott (NYSE: ABT) today presented 48-week findings comparing an HIV
regimen of its protease inhibitor (PI), Kaletra(R) (lopinavir/ritonavir), and
Merck's integrase inhibitor, Isentress(R) (raltegravir), to a traditional HIV
regimen of Kaletra and the [...]

Bill Gates: World Has Historic Opportunity to ‘Change the Face of AIDS’

In Keynote Speech to AIDS Conference, Gates Outlines Roadmap to Reduce Annual New HIV Infections 90% by 2031

VIENNA, July 19, 2010 – Speaking to the 18th International AIDS Conference today, Bill Gates
called on all countries to keep up the fight against HIV/AIDS, saying the
world has an historic opportunity to "change the face of AIDS." [...]

Corgenix Medical Corp. and the ELITech Group Establish Strategic Alliance

Terms include initial US$1.25 million ELITech equity investment in Corgenix with options for US$3 million total, plus distribution agreement and diagnostic system co-development

DENVER and PARIS, July 19, 2010 – Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide
developer and marketer of diagnostic test kits, and the ELITech Group, a
Paris, France-based, privately held group of [...]

Amira Pharmaceuticals Hits Two Development Milestones Related to FLAP Inhibitor Program

SAN DIEGO, July 19, 2010 – "Amira Pharmaceuticals, Inc. announced today that its FLAP
(5-lipoxygenase-activating protein) program, which is partnered with
GlaxoSmithKline, has achieved two clinical development milestones."

These milestones are related to the successful progression of the program
to Phase 2 studies, which explore the use of the Amira discovered FLAP
inhibitor in patients [...]

International Organizations Agree to Take Concerted Action to End Pediatric HIV/AIDS

"No child should enter this world infected with HIV."
VIENNA, July 19, 2010 – A global alliance of international organizations, including the heads of
UNICEF, UNAIDS and The Global Fund to Fight AIDS, Tuberculosis and Malaria as
well as other NGOs including the Pan African Treatment Access Movement,
Health GAP, Ugandan Pediatric Association and the Global AIDS Alliance [...]

MarketsandMarkets: Global Bioinformatics Market Worth $8.3 billion by 2014

DALLAS, July 21, 2010 – According to the new market research report "Bioinformatics Market -
Advanced Technologies, Global Forecast and Winning Imperatives (2009-2014)",
published by MarketsandMarkets (www.marketsandmarkets.com), the global
bioinformatics market is expected to reach a $8.3 billion by 2014 at a high
CAGR of 24.8% from 2009-2014. While knowledge management formed the largest
submarket is 2009 at $1.3 [...]

Eye Care Company Leader Alcon Japan Ltd. Goes Live With Varicent to Automate Their Incentive Compensation System

Varicent solution to enable modeling and forecasting functionality as well as business ownership

TORONTO, July 21, 2010 – The leading innovator in incentive compensation (ICM) and sales
performance management (SPM) solutions, Varicent Software Incorporated,
announced today a successful "go live" of Varicent for Alcon Japan Ltd.
After a thorough survey of SPM products, Alcon [...]

Concentric Medical Announces First Stroke Patients Treated With the Merci Retriever(R) in Japan

MOUNTAIN VIEW, California, July 21, 2010 – Concentric Medical, Inc., the global leader in devices for clot removal
in acute ischemic stroke patients, today announced the treatment of the first
patient in Japan with the Merci Retriever(R). The Merci Retriever is a
catheter-based medical device that stroke centers use to remove blood clots
from the brains of patients [...]

Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Ongoing Earnings Growth Outlook for 2010

ABBOTT PARK, Illinois, July 21, 2010 -

– Second Quarter Ongoing EPS Growth of 13.5 Percent -
– Worldwide Sales Increased 17.8 Percent -
– Strong Performance Across Diverse Businesses -
– Accelerated Emerging Markets Leadership -
– Enhanced [...]

GlaxoSmithKline CEO Interviewed On Half-Year and Q2 Results

LONDON, July 21, 2010 – In an interview with financial broadcaster www.cantos.com,
GlaxoSmithKline CEO Andrew Witty says one-offs held back sales growth in Q2
but highlights the strong underlying performance of Emerging Markets,
Consumer and Vaccines.

The Pharma boss also points to "an unprecedented" five new drugs in late
stage trials as a sign of [...]

Netter Products Expand Offerings to Include Interactive Online and Mobile Technologies

Medicine's Most Well Known Anatomy Products Offer Students and Medical Professionals Online and Mobile Tools to aid Learning and Review

PHILADELPHIA, July 21, 2010 – Netter Products (www.netterimages.com/), which are based on
medicine's most well known and comprehensive collection of hand-painted
anatomy illustrations by Frank Netter, M.D, have evolved into sophisticated
digital tools that aid students and clinicians [...]

Largest U.S. Surrogacy Agency Traveling to London to Host Private Consultations – Agency Now Offering the First Ever Surrogacy Financing Program

LOS ANGELES, July 22, 2010 – Since 1996, Growing Generations has been a company passionately dedicated
to the vision of creating life and, in the process, changing the world. Its
mission is simple – to build families of choice for all communities through
surrogacy, egg donation, and sperm donation. To build on this mission,
Growing Generations is excited [...]

London Genetics Expands its Senior Advisory Team

LONDON, July 22, 2010 – London Genetics Limited, an expert in the use of pharmacogenetics in
clinical drug discovery and development, is pleased to announce that it
has augmented the strength of its team with the appointment of two senior
advisers, Professors Stephen DeCherney and Munir Pirmohamed. With their
extensive clinical, healthcare, and drug development expertise, their
guidance will [...]

Lost and Found: L2FU Recovers 100% of Clinical Trial Patients for Recent Pivotal Study

Patients 'lost' from a clinical trial result in study delays, increased patient recruitment costs and compromised study data. L2FU provides critical solutions.

KING OF PRUSSIA, Pennsylvania, July 22, 2010 – Recovering unnecessarily lost patient information is now a viable
reality. Lost to follow up (L2FU) rates in clinical research trials can range
from 20- 60%. As a [...]